Human Recombinant VEGF-C, STEMCELL Technologies (CAT#: STEM-CT-0964-ZJF)

Vascular endothelial growth factor C (VEGF-C) is a member of the VEGF/platelet-derived growth factor (PDGF) family of proteins. VEGF-C is a potent angiogenic factor and promotes lymphangiogenesis, endothelial cell growth and survival, and can affect blood vessel permeability. VEGF-C is expressed in a range of tissues, but is not expressed in peripheral blood lymphocytes. VEGF-C forms a non-covalent, cell surface-associated, disulfide-linked homodimer that can bind and activate VEGF receptors 2 (VEGFR-2 [Flk1]) and 3 (VEGFR-3 [Flt4]). Interaction with VEGFR-2 results in physiological and intratumoral neoangiogenesis and vessel sprouting (Cao et al.; Tammela et al.), whereas interaction with VEGFR-3 is critical for lymphangiogenesis (Karkkainen et al.; Laakkonen et al.; Mäkinen et al.). Overexpression of VEGF-C in tumor cells has been shown to result in enhanced lymph flow and increased metastasis to regional lymph nodes (Hoshida et al.; Mandriota et al.; Padera et al.; Skobe et al.).

Subtype: Cytokines, Growth Factors
Alternatives Names: Flt4-L, Flt4 ligand, Vascular endothelial growth factor C, Vascular endothelial growth factor-related protein, VRP
Cell Type: Endothelial Cells
Species: Human
Area of Interest: Endothelial Cell Biology
Molecular Weight: 13.2 kDa
Purity: ≥ 95%

Reliable Consistency: Guarantees uniformity and repeatability in various applications with endotoxin levels below 0.2 EU/μg.
Free of Animal Components: Completely devoid of any animal or human-derived elements.
Broad Selection: Offers a wide range of human, mouse, and rat cytokines available in multiple sizes.

Human Recombinant VEGF-165, STEMCELL Technologies
Human Recombinant VEGF-165, ACF, STEMCELL Technologies
Human Recombinant VEGF-D, STEMCELL Technologies
Human Recombinant bFGF, ACF, STEMCELL Technologies